|
Email |
| |
Awards |
|
|
Research Fellowship Acute Coronary Syndrome, German Society of Cardiology
Gonda (Goldschmied) Diabetes Center Research Fellowship, University of California, Los Angeles
Finalist AstraZeneca Cardiovascular Young Investigators Forum
New Investigator Award, Council for High Blood Pressure Research, American Heart Association
Young Investigator Award Basic Science (1. Prize), European Society of Cardiology
Young Investigator Award, The Endocrine Society
ATVB Merit Award for Young Investigators, Council on Arteriosclerosis, Thrombosis and Vascular Biology, American Heart Association
Pilot and Feasibility Grant Award, University of California, Los Angeles and San Diego
Young Scholar Award, American Society of Hypertension
National Scientist Development Grant, American Heart Association
Physician-Scientist Award, University of Kentucky
Irvine H. Page Young Investigator Research Award, Council on Arteriosclerosis, Thrombosis and Vascular Biology, American Heart Association
|
| |
Clinical Interests |
|
|
Dr. Bruemmer has a special interest in Preventive Medicine and Cardiovascular Risk Factor reduction including the
treatment of Type 2 diabetes, hyperlipidemia, and hypertension.
|
| |
Research Interests |
|
|
Dr. Bruemmer's research interest is in the transcriptional control of cell proliferation by nuclear
hormone receptors in vascular biology and adipose tissue. In particular, he studies the regulation of
telomerase as a transcriptional target for nuclear receptors and its function in the control of cellular
proliferation during vascular remodeling and adipose tissue aging. Dr. Bruemmer is funded by the NIH/NHLBI,
the American Diabetes Association, the Commonwealth of Kentucky, and through direct fellowship stipends by the
American Heart Association.
|
